Diabetes drug maker once skyrocketed nearly 3 times on debut

Diabetes drug maker Guangzhou Innogen Pharmaceutical Group (2591) once jumped 296 percent to HK$72 on the debut, giving a paper gain of HK$11,064 per board lot of 200 shares.

Its shares surged 10 percent to HK$50.60 from its offer price at HK$18.68 as of 11am. 

The drug maker reportedly pulled in margin loans of HK$370 billion with its retail tranche 5,364 times oversubscribed.

Innogen earlier plans to raise HK$683 billion, with a minimum investment of HK$3,773.7.

STAFF REPORTER